Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Fibrin clot strength measured by thrombelastography and outcomes after percutaneous coronary intervention.

Kreutz RP, Schmeisser G, Maatman B, Schaffter A, Sinha A, von der Lohe E, Breall JA.

Thromb Haemost. 2017 Jan 26;117(2):426-428. doi: 10.1160/TH16-10-0496. Epub 2016 Nov 3. No abstract available.

PMID:
27808346
2.

Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention.

Kreutz RP, Breall JA, Sinha A, von der Lohe E, Kovacs RJ, Flockhart DA.

Clin Pharmacol. 2016 Jun 3;8:45-50. doi: 10.2147/CPAA.S98790. eCollection 2016.

3.

Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.

Kreutz RP, Bitar A, Owens J, Desta Z, Breall JA, von der Lohe E, Sinha A, Vatta M, Nystrom P, Jin Y, Flockhart DA.

J Thromb Thrombolysis. 2014 Oct;38(3):380-7. doi: 10.1007/s11239-014-1059-4.

4.

C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.

Kreutz RP, Owens J, Breall JA, Lu D, von der Lohe E, Bolad I, Sinha A, Flockhart DA.

Blood Coagul Fibrinolysis. 2013 Apr;24(3):321-6. doi: 10.1097/MBC.0b013e32835cc193.

5.

Strategies for multivessel revascularization in patients with diabetes.

Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas G, Mack M, Yang M, Cohen DJ, Rosenberg Y, Solomon SD, Desai AS, Gersh BJ, Magnuson EA, Lansky A, Boineau R, Weinberger J, Ramanathan K, Sousa JE, Rankin J, Bhargava B, Buse J, Hueb W, Smith CR, Muratov V, Bansilal S, King S 3rd, Bertrand M, Fuster V; FREEDOM Trial Investigators.

N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.

6.

Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel response.

Kreutz RP, Breall JA, Kreutz Y, Owens J, Lu D, Bolad I, von der Lohe E, Sinha A, Flockhart DA.

Thromb Res. 2012 Aug;130(2):198-202. doi: 10.1016/j.thromres.2012.02.049. Epub 2012 Mar 28.

7.

Cardiac events after non-cardiac surgery in patients with previous coronary intervention in the drug-eluting stent era.

Bolad IA, Alqaqa'a A, Khan B, Srivastav SK, von der Lohe E, Sadanandan S, Breall JA.

J Invasive Cardiol. 2011 Jul;23(7):283-6.

8.

Takotsubo cardiomyopathy in a patient with esophageal cancer: a case report.

Gangadhar TC, Von der Lohe E, Sawada SG, Helft PR.

J Med Case Rep. 2008 Dec 8;2:379. doi: 10.1186/1752-1947-2-379.

9.

Factors associated with poor survival in women experiencing cardiac arrest in a rural setting.

Cline SL, von Der Lohe E, Newman MM, Groh WJ.

Heart Rhythm. 2005 May;2(5):492-6.

PMID:
15840473
10.

Coincidence of true and false aneurysm with rupture into the right atrium.

George ZH, Meltser H, Zelenka J, Von der Lohe E.

J Invasive Cardiol. 2004 Sep;16(9):518-20. Review. No abstract available.

PMID:
15353810
11.

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators.

N Engl J Med. 2003 Nov 13;349(20):1893-906. Epub 2003 Nov 10. Erratum in: N Engl J Med. 2004 Jan 8;350(2):203.

12.

Combined distal embolization protection and rheolytic thrombectomy to facilitate percutaneous revascularization of totally occluded saphenous vein grafts.

Gaitonde RS, Sharma N, von der Lohe E, Kalaria VG.

Catheter Cardiovasc Interv. 2003 Oct;60(2):212-7.

PMID:
14517927
13.

Comparison of left ventriculography and coronary arteriography with positron emission tomography in assessment of myocardial viability.

Bourdillon PD, von der Lohe E, Lewis SJ, Sharifi M, Burt RW, Sawada SG.

Clin Cardiol. 2003 Feb;26(2):60-6.

14.

What's bad for the gander...women and sudden cardiac death.

Groh WJ, von der Lohe E, Zipes DP.

Heart. 2002 Dec;88(6):553-4. No abstract available.

15.

Sex steroids and cardiac arrhythmia: more questions than answers.

Rubart M, von der Lohe E.

J Cardiovasc Electrophysiol. 1998 Jun;9(6):665-7. No abstract available.

PMID:
9654235
16.

The comparison of 2-18F-2-deoxyglucose and 15-(ortho-123I-phenyl)-pentadecanoic acid uptake in persisting defects on thallium-201 tomography in myocardial infarction.

Henrich MM, Vester E, von der Lohe E, Herzog H, Simon H, Kuikka JT, Feinendegen LE.

J Nucl Med. 1991 Jul;32(7):1353-7.

18.

[Exercise electrocardiogram and coronary angiography after myocardial infarct].

Sechtem U, von der Lohe E.

Dtsch Med Wochenschr. 1987 May 29;112(22):867-72. German.

PMID:
3582196
19.

[Resection of the septum im hypertrophic obstructive cardiomyopathy. Long-term results in 33 patients].

von der Lohe E, Müller-Haake C, Minale C, von Essen R, Effert S, Messmer BJ.

Dtsch Med Wochenschr. 1984 Nov 16;109(46):1749-53. German.

PMID:
6541993

Supplemental Content

Loading ...
Support Center